/biz/ - Business & Finance

> long plays here, priced low, have lots of cash
>MDWD (mediwound ltd)
Has a treatment for burns - Nexobrid which is made from pineapple enzymes (meme potential) that is allows to treat serious burns without complex surgeries. No competition. Has been in use for a long time, approved in EU, pending approval in US. Gov stockpiling contracts down the road. Has a partnership for upcoming sales with Vericel which is currently hiring a lot of sales reps. Has another product in Phase II which pretty much will seal their mkt leadership. This stock is the golden goose.
> ODT (odonate therapeutics)
Is currently developing a more effective and less dangerous treatment for breast cancer. The study is in Phase III. Cancer rates are going up and the TAM is big. Approval is almost certain. Catalysts will come mid to late 2021. Heavy backing from Tang Capital and Boxer Capital. Insiders are buying.
>MREO ( mereo biopharma)
Develops a couple of treatments for rare diseases/tumors, most of them are in phase I & II, but the gamechangers are in late phase. Has partnerships with the OG's on some of them. Catalysts around mid-late 2021, early 2022. Recently doubled, weak hands and algos got out, investors scooped all the shares up so no overhead baggies to fuck up the show. Boxer cap is one of the major buyers.
These are plays I'm holding for the next 1 to 2 years, 10% of folio and expecting solid triple digit profits. DYOR. Capped my opinion for memes.

>TAKE THE DIP PILL

>>20808084
>We were somewhere around Barstow, on the edge of the desert, when the drugs began to take hold.